2020-05-23 03:08:42 source: Xinhua
(File photo: CGTN)
China's COVID-19 vaccine trial, the first such vaccine to reach phase 1 clinical trial, has been found to be safe, well-tolerated, and able to generate an immune response against SARS-COV-2 in humans, according to a study published online on Friday by the medical journal The Lancet.
read more